Join
Live feed
·
PRReleasevia Quantisnow
Seneca Biopharma, Inc. logo

Leading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions in Open Label Study

ByQuantisnow·Wall Street's wire, on your screen.
SNCA· Seneca Biopharma, Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNCA (Seneca Biopharma, Inc.) and more on Quantisnow.